Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis

MJ Shearer, P Newman - Journal of Lipid Research, 2014 - ASBMB
In contrast to other fat-soluble vitamins, dietary vitamin K is rapidly lost to the body resulting
in comparatively low tissue stores. Deficiency is kept at bay by the ubiquity of vitamin K in the …

[HTML][HTML] Structural and functional insights into enzymes of the vitamin K cycle

JK Tie, DW Stafford - Journal of Thrombosis and Haemostasis, 2016 - Elsevier
Vitamin K‐dependent proteins require carboxylation of certain glutamates for their biological
functions. The enzymes involved in the vitamin K‐dependent carboxylation include: gamma …

A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase

DY Jin, X Chen, Y Liu, CM Williams… - Nature …, 2023 - nature.com
Vitamin K is a vital micronutrient implicated in a variety of human diseases. Warfarin, a
vitamin K antagonist, is the most commonly prescribed oral anticoagulant. Patients …

Key pathways and regulators of vitamin K function and intermediary metabolism

MJ Shearer, T Okano - Annual review of nutrition, 2018 - annualreviews.org
Vitamin K (VK) is an essential cofactor for the post-translational conversion of peptide-bound
glutamate to γ-carboxyglutamate. The resultant vitamin K–dependent proteins are known or …

Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact

MA Chiasson, NJ Rollins, JJ Stephany, KA Sitko… - elife, 2020 - elifesciences.org
Vitamin K epoxide reductase (VKOR) drives the vitamin K cycle, activating vitamin K-
dependent blood clotting factors. VKOR is also the target of the widely used anticoagulant …

Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation

S Liu, S Li, G Shen, N Sukumar, AM Krezel, W Li - Science, 2021 - science.org
INTRODUCTION Vitamin K antagonists (VKAs), such as warfarin, are oral anticoagulants
commonly used to treat and prevent thromboembolic diseases, including stroke and heart …

Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer

G Shen, W Cui, H Zhang, F Zhou, W Huang… - Nature structural & …, 2017 - nature.com
Although warfarin is the most widely used anticoagulant worldwide, the mechanism by
which warfarin inhibits its target, human vitamin K epoxide reductase (hVKOR), remains …

GGCX and VKORC1 inhibit osteocalcin endocrine functions

M Ferron, J Lacombe, A Germain, F Oury… - Journal of Cell …, 2015 - rupress.org
Osteocalcin (OCN) is an osteoblast-derived hormone favoring glucose homeostasis, energy
expenditure, male fertility, brain development, and cognition. Before being secreted by …

Measuring pharmacogene variant function at scale using multiplexed assays

RC Geck, G Boyle, CJ Amorosi… - Annual Review of …, 2022 - annualreviews.org
As costs of next-generation sequencing decrease, identification of genetic variants has far
outpaced our ability to understand their functional consequences. This lack of understanding …

Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition

S Wu, X Chen, DY Jin, DW Stafford… - Blood, The Journal …, 2018 - ashpublications.org
Vitamin K epoxide reductase (VKOR), an endoplasmic reticulum membrane protein, is the
key enzyme for vitamin K–dependent carboxylation, a posttranslational modification that is …